Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/473,876external-prioritypatent/US5705524A/en
Application filed by Gilead Sciences IncfiledCriticalGilead Sciences Inc
Priority claimed from PCT/US1995/014603external-prioritypatent/WO1996014314A2/en
Publication of NZ297230ApublicationCriticalpatent/NZ297230A/en
Measuring Or Testing Involving Enzymes Or Micro-Organisms
(AREA)
Abstract
Patent 297230 The specification describes tri- and tetra substituted thiepanes of above formula(I) and compositions having use as immunogens and diagnostics. Y is O, S, SO, SO2, N(R1), N(R2)SO2, N(R1)CO, or OSO2. The compositions inhibit proteolytic activity of viral enzymes and are useful for the inhibition of such enzymes as well as in assays for the detection of such enzymes. Embodiments in which antigenic polypeptides are bonded to the compositions are useful in raising antibodies against the thiepane haptens or the polypeptide. Labelled thiepanes are useful as diagnostic reagents.
NZ297230A1994-11-021995-11-03Thiepane compounds for detecting HIV protease
NZ297230A
(en)